Literature DB >> 20213293

Diabetics on hemodialysis in El-Minia Governorate, Upper Egypt: five-year study.

Osama El-Minshawy1, Emad G Kamel.   

Abstract

INTRODUCTION: The number of patients with end-stage renal disease (ESRD) due to diabetic nephropathy (DN) is increasing worldwide. In many countries, diabetes mellitus has become the most frequent cause of ESRD. The goal of this work is to critically evaluate the prevalence of DN among chronic regular hemodialysis (HD) patients in El-Minia Governorate, to evaluate changes over the course of 5 years, and to compare data of El-Minia Governorate with data from the United States and other countries, in an attempt to detect factors that might explain causes of the differences.
MATERIAL AND METHODS: Data of patients on HD enrolled in the annual registry of the causes of ESRD in El-Minia Governorate were evaluated during the period from 2004 to 2008 for prevalence of DN. ESRD related to diabetes was defined as people who were initiated on chronic regular HD with diabetes mellitus as the cause of ESRD.
RESULTS: The prevalence of DN among HD patients increased from 5% in 2004 to 16% in 2008. The mean age was significantly higher than that of ESRD patients on HD due to other etiologies. Furthermore, DN was more prevalent in urban areas than rural areas.
CONCLUSION: Diabetic nephropathy among HD patients in El-Minia Governorate is increasing but is less prevalent than in the United States and other Western countries, probably because of a higher incidence of other causes of ESRD in El-Minia governorate, or because of premature death of diabetic patients. Therefore, meticulous management of diabetic patients is mandatory.

Entities:  

Mesh:

Year:  2010        PMID: 20213293     DOI: 10.1007/s11255-010-9713-z

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  27 in total

Review 1.  The diabetic foot in the dialyzed patient.

Authors:  Michael Schömig; Eberhard Ritz; Eberhard Standl; Jens Allenberg
Journal:  J Am Soc Nephrol       Date:  2000-06       Impact factor: 10.121

2.  Higher incidence of diabetic nephropathy in type 2 than in type 1 diabetes in early-onset diabetes in Japan.

Authors:  N K Hollenberg
Journal:  Curr Hypertens Rep       Date:  2001-06       Impact factor: 5.369

3.  Poor long-term survival after acute myocardial infarction among patients on long-term dialysis.

Authors:  C A Herzog; J Z Ma; A J Collins
Journal:  N Engl J Med       Date:  1998-09-17       Impact factor: 91.245

4.  Prevalence and clinical correlates of coronary artery disease among new dialysis patients in the United States: a cross-sectional study.

Authors:  Austin G Stack; Wendy E Bloembergen
Journal:  J Am Soc Nephrol       Date:  2001-07       Impact factor: 10.121

5.  Diabetes mellitus in Egypt: risk factors and prevalence.

Authors:  W H Herman; M A Ali; R E Aubert; M M Engelgau; S J Kenny; E W Gunter; A M Malarcher; R J Brechner; S F Wetterhall; F DeStefano
Journal:  Diabet Med       Date:  1995-12       Impact factor: 4.359

6.  Diabetic nephropathy and end-stage renal failure: the Norwegian story.

Authors:  H Bergrem; T Leivestad
Journal:  Adv Ren Replace Ther       Date:  2001-01

7.  Thrifty genes for obesity, an attractive but flawed idea, and an alternative perspective: the 'drifty gene' hypothesis.

Authors:  J R Speakman
Journal:  Int J Obes (Lond)       Date:  2008-10-14       Impact factor: 5.095

8.  Diabetic nephropathy in hemodialysis patients in casablanca.

Authors:  N Khanfri; G Medkouri; R Aghai; K Hachim; M G Benghanem; B Ramdani; D Zaid
Journal:  Saudi J Kidney Dis Transpl       Date:  2005 Jan-Mar

Review 9.  Could mitochondrial efficiency explain the susceptibility to adiposity, metabolic syndrome, diabetes and cardiovascular diseases in South Asian populations?

Authors:  Raj S Bhopal; Snorri B Rafnsson
Journal:  Int J Epidemiol       Date:  2009-05-07       Impact factor: 7.196

10.  Epidemiology of hemodialysis patients in Aleppo city.

Authors:  Ghamez Moukeh; Rabi Yacoub; Fadi Fahdi; Samer Rastam; Sami Albitar
Journal:  Saudi J Kidney Dis Transpl       Date:  2009-01
View more
  2 in total

1.  Metabolic control and vascular diseases under oral antidiabetic drug versus insulin therapy and/or diet alone during the first year of hemodialysis in type 2 diabetic patients with ESRD.

Authors:  Georg Biesenbach; Gert Bodlaj; Stephan Ebner; Peter Biesenbach; Herwig Pieringer
Journal:  Int Urol Nephrol       Date:  2010-07-20       Impact factor: 2.370

Review 2.  Abnormalities of serum potassium concentration in dialysis-associated hyperglycemia and their correction with insulin: review of published reports.

Authors:  Antonios H Tzamaloukas; Todd S Ing; Moses S Elisaf; Dominic S C Raj; Kostas C Siamopoulos; Mark Rohrscheib; Glen H Murata
Journal:  Int Urol Nephrol       Date:  2010-09-09       Impact factor: 2.370

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.